{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:52:55Z","timestamp":1780483975858,"version":"3.54.1"},"reference-count":43,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the rate of inactive disease in children with juvenile idiopathic arthritis (JIA) treated with etanercept, and to identify clinical characteristics associated with attainment of inactive disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Clinical charts of patients who were given etanercept between January 2002 and January 2011 were evaluated retrospectively. For each patient, all visits from initiation of etanercept to the last followup evaluation in which the patient was still receiving etanercept were examined to establish whether the patient had reached the state of inactive disease and to identify the first visit in which inactive disease was documented. Clinical characteristics associated with achievement of inactive disease were determined through univariate analyses and Cox regression procedures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>A total of 173 patients who received etanercept for a median of 2.2 years (range 0.5\u201310.5 yrs) were studied. Eighty-seven patients (50.3%) achieved inactive disease after a median of 0.6 years (range 0.1\u20132.5 yrs) of therapy. At last followup evaluation, 85 patients (49.1%) still had inactive disease and 70 (40.5%) were in clinical remission on medication. The probability of achievement of inactive disease after 6, 12, and 24 months of therapy was 24%, 46% and 57%, respectively. On Cox regression analysis, the attainment of inactive disease was associated with lack of wrist involvement and an age at disease onset &lt; 3.6 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Around half of our patients with JIA treated with etanercept achieved a state of inactive disease. Children who lacked wrist involvement and were younger at disease onset had a greater likelihood of achieving inactive disease.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.120842","type":"journal-article","created":{"date-parts":[[2012,12,2]],"date-time":"2012-12-02T03:31:59Z","timestamp":1354419119000},"page":"192-200","source":"Crossref","is-referenced-by-count":44,"title":["Factors Associated with Achievement of Inactive Disease in Children with Juvenile Idiopathic Arthritis Treated with Etanercept"],"prefix":"10.3899","volume":"40","author":[{"given":"NICOLETTA","family":"SOLARI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELENA","family":"PALMISANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALESSANDRO","family":"CONSOLARO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANGELA","family":"PISTORIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFANIA","family":"VIOLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONELLA","family":"BUONCOMPAGNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARCO","family":"GATTORNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAOLO","family":"PICCO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICOLINO","family":"RUPERTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CLARA","family":"MALATTIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALBERTO","family":"MARTINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANGELO","family":"RAVELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"2018112909311446000_40.2.192.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60363-8"},{"key":"2018112909311446000_40.2.192.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.13.1671"},{"key":"2018112909311446000_40.2.192.3","doi-asserted-by":"publisher","DOI":"10.1186\/ar2619"},{"key":"2018112909311446000_40.2.192.4","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2011.581662"},{"key":"2018112909311446000_40.2.192.5","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909311446000_40.2.192.6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20497"},{"issue":"Suppl 43","key":"2018112909311446000_40.2.192.7","first-page":"S105","article-title":"Remission in juvenile idiopathic arthritis","volume":"24","author":"Ravelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909311446000_40.2.192.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23916"},{"key":"2018112909311446000_40.2.192.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133033"},{"key":"2018112909311446000_40.2.192.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.27670"},{"key":"2018112909311446000_40.2.192.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.34343"},{"key":"2018112909311446000_40.2.192.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003163421103"},{"key":"2018112909311446000_40.2.192.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.10885"},{"key":"2018112909311446000_40.2.192.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014886"},{"key":"2018112909311446000_40.2.192.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.24777"},{"key":"2018112909311446000_40.2.192.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-0942-3"},{"key":"2018112909311446000_40.2.192.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111260"},{"key":"2018112909311446000_40.2.192.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.27682"},{"key":"2018112909311446000_40.2.192.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq123"},{"key":"2018112909311446000_40.2.192.20","first-page":"688","article-title":"Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis","volume":"26","author":"Nielsen","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909311446000_40.2.192.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq292"},{"key":"2018112909311446000_40.2.192.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1671"},{"key":"2018112909311446000_40.2.192.23","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909311446000_40.2.192.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.30076"},{"key":"2018112909311446000_40.2.192.25","unstructured":"Clayton D Hills M . Statistical models in epidemiology. New York: Oxford University Press; 1993."},{"key":"2018112909311446000_40.2.192.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.11337"},{"key":"2018112909311446000_40.2.192.27","first-page":"637","article-title":"Unilateral destructive wrist synovitis in juvenile idiopathic arthritis","volume":"22","author":"Cassone","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909311446000_40.2.192.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.24313"},{"key":"2018112909311446000_40.2.192.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.10544"},{"key":"2018112909311446000_40.2.192.30","first-page":"1805","article-title":"Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis","volume":"32","author":"Felici","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909311446000_40.2.192.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6942(02)90233-0"},{"key":"2018112909311446000_40.2.192.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70127-7"},{"key":"2018112909311446000_40.2.192.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120840"},{"key":"2018112909311446000_40.2.192.34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087593"},{"key":"2018112909311446000_40.2.192.35","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909311446000_40.2.192.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087411"},{"key":"2018112909311446000_40.2.192.37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq308"},{"key":"2018112909311446000_40.2.192.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087130"},{"key":"2018112909311446000_40.2.192.39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050473"},{"key":"2018112909311446000_40.2.192.40","first-page":"929","article-title":"Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?","volume":"25","author":"De Benedetti","year":"1998","journal-title":"J Rheumatol"},{"issue":"Suppl 3","key":"2018112909311446000_40.2.192.41","first-page":"90","article-title":"Silent arthritis in JIA children with clinically inactive disease detected by MRI","volume":"70","author":"Tzaribachev","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2018112909311446000_40.2.192.42","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20478"},{"key":"2018112909311446000_40.2.192.43","doi-asserted-by":"crossref","unstructured":"Magni-Manzoni S Scir\u00e8 CA Ravelli A Klersy C Rossi S Muratore V Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis. Ann Rheum Dis 2012 June 26 [E-pub ahead of print].","DOI":"10.1136\/annrheumdis-2011-201264"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.120842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T09:39:31Z","timestamp":1562405971000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.120842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3899\/jrheum.120842"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.120842","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}